Adherence and out‐of‐pocket costs among Medicare beneficiaries who are prescribed oral targeted therapies for advanced prostate cancer-Reference-Cited by-同舟云学术

Adherence and out‐of‐pocket costs among Medicare beneficiaries who are prescribed oral targeted therapies for advanced prostate cancer

Published:2020-09-14 Issue:23 Volume:126 Page:5050-5059
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Caram Megan E. V.¹²^ORCID,Oerline Mary K.³,Dusetzina Stacie⁴^ORCID,Herrel Lindsey A.³,Modi Parth K.³^ORCID,Kaufman Samuel R.³,Skolarus Ted A.²³^ORCID,Hollenbeck Brent K.³,Shahinian Vahakn¹³

Affiliation:

1. Department of Internal Medicine University of Michigan Medical School Ann Arbor Michigan

2. Ann Arbor VA Center for Clinical Management Research VA Health Services Research and Development, VA Ann Arbor Healthcare System Ann Arbor Michigan

3. Department of Urology University of Michigan Medical School Ann Arbor Michigan

4. Department of Health Policy Vanderbilt University Medical Center Nashville Tennessee

Funder

Agency for Healthcare Research and Quality

Prostate Cancer Foundation

National Cancer Institute

Commonwealth Fund

Leukemia and Lymphoma Society

Publisher

Wiley

Subject

Cancer Research,Oncology